Nascent Biotech Inc. Quarterly Operating Income (Loss) in USD from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Nascent Biotech Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q4 2013 to Q2 2024.
  • Nascent Biotech Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$376K, a 26.6% increase year-over-year.
  • Nascent Biotech Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$2.09M, a 2.22% decline year-over-year.
  • Nascent Biotech Inc. annual Operating Income (Loss) for 2023 was -$2.23M, a 3.44% decline from 2022.
  • Nascent Biotech Inc. annual Operating Income (Loss) for 2022 was -$2.16M, a 372% decline from 2021.
  • Nascent Biotech Inc. annual Operating Income (Loss) for 2021 was -$457K, a 67.4% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$2.09M -$376K +$136K +26.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$2.23M -$516K +$23.8K +4.41% Jan 1, 2024 Mar 31, 2024 10-K 2024-07-01
Q4 2023 -$2.25M -$364K +$111K +23.3% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-14
Q3 2023 -$2.36M -$837K -$316K -60.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$2.05M -$512K +$108K +17.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$2.16M -$540K -$125K -30.1% Jan 1, 2023 Mar 31, 2023 10-K 2024-07-01
Q4 2022 -$2.03M -$475K -$1.11M -175% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q3 2022 -$925K -$521K -$291K -126% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$634K -$620K -$177K -39.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-18
Q1 2022 -$457K -$415K -$682K -255% Jan 1, 2022 Mar 31, 2022 10-K/A 2023-07-03
Q4 2021 $225K $631K +$1.19M Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q3 2021 -$961K -$230K +$331K +59% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$1.29M -$443K +$109K +19.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$1.4M $267K +$2.74M Jan 1, 2021 Mar 31, 2021 10-K 2022-06-15
Q4 2020 -$4.15M -$555K -$187K -50.7% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 -$3.96M -$561K -$233K -71.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$3.72M -$551K -$278K -101% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$3.45M -$2.48M -$2.14M -640% Jan 1, 2020 Mar 31, 2020 10-K 2021-07-08
Q4 2019 -$1.3M -$368K -$112K -43.5% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-09
Q3 2019 -$1.19M -$328K +$10.5K +3.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$1.2M -$274K +$166K +37.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$1.37M -$335K +$467K +58.2% Jan 1, 2019 Mar 31, 2019 10-K 2020-06-22
Q4 2018 -$1.84M -$257K +$307K +54.5% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-11
Q3 2018 -$2.14M -$338K +$220K +39.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-18
Q2 2018 -$2.36M -$440K -$141K -47.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$2.22M -$801K -$337K -72.6% Jan 1, 2018 Mar 31, 2018 10-K 2019-07-12
Q4 2017 -$1.88M -$564K +$6.08K +1.07% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-13
Q3 2017 -$1.89M -$558K -$2.29M -132% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 $399K -$299K -$1.03M -141% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 $1.43M -$464K +$133K +22.2% Jan 1, 2017 Mar 31, 2017 10-K 2018-06-29
Q4 2016 $1.29M -$570K -$304K -114% Oct 1, 2016 Dec 31, 2016 10-Q 2018-01-31
Q3 2016 $1.6M $1.73M +$3.98M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 -$2.38M $730K +$1.49M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$3.87M -$597K +$317K +34.7% Jan 1, 2016 Mar 31, 2016 10-K 2017-06-29
Q4 2015 -$4.19M -$266K +$389K +59.4% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-09
Q3 2015 -$4.58M -$2.25M -$1.92M -596% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$2.65M -$760K -$529K -228% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$2.12M -$914K Jan 1, 2015 Mar 31, 2015 10-K 2016-07-14
Q4 2014 -$655K -$589K -900% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-19
Q3 2014 -$323K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 -$232K Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-30
Q4 2013 -$65.4K Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.